Alterations in central fatigue by pharmacological manipulations of neurotransmitters in normal and high ambient temperature

Sports Medicine

Volumn 40, Issue 3, 2010, Pages 229-246

  Roelands, Bart ^a   Meeusen, Romain ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CAFFEINE; CENTRAL STIMULANT AGENT; DOPAMINE; NORADRENALIN; SEROTONIN;

ANIMAL; BODY TEMPERATURE; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; FATIGUE; FEVER; HUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHYSIOLOGY; REVIEW; TEMPERATURE; THERMOREGULATION;

ANIMALS; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; CAFFEINE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; FATIGUE; FEVER; HUMANS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PERIPHERAL NERVOUS SYSTEM; SEROTONIN; TEMPERATURE;

EID: 77749239996     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.2165/11533670-000000000-00000     Document Type: Review

References (122)

1. St Clair Gibson A, Baden DA, Lambert MI, et al. The conscious perception of the sensation of fatigue. Sports Med 2003; 33 (3): 167-176
2. Edwards RH. Human muscle function and fatigue. Ciba Found Symp 1981; 82: 1-18
3. Booth FW, Thomason DB. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol Rev 1991; 71 (2): 541-585
4. Davis JM, Bailey SP. Possible mechanisms of central nervous system fatigue during exercise. Med Sci Sports Exerc 1997; 29 (1): 45-57
5. Nybo L, Secher NH. Cerebral perturbations provoked by prolonged exercise. Prog Neurobiol 2004; 72 (4): 223-261
6. Taylor JL, Todd G, Gandevia SC. Evidence for a supraspinal contribution to human muscle fatigue. Clin Exp Pharmacol Physiol 2006; 33: 400-405
7. St Clair Gibson A, Lambert EV, Rauch LH, et al. The role of information processing between the brain and peripheral physiological systems in pacing and perception of effort. Sports Med 2006; 36 (8): 705-722
8. Marino FE. Anticipatory regulation and avoidance of catastrophe during exercise-induced hyperthermia. Comp Biochem Physiol B Biochem Mol Biol 2004; 139 (4): 535-538
9. Noakes TD, St Clair Gibson A, Lambert EV. From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans. Br J Sports Med 2004; 38 (4): 511-514
10. Meeusen R, Watson P, Hasegawa H, et al. Central fatigue: the serotonin hypothesis and beyond. Sports Med 2006; 36 (10): 881-909
11. Green HJ. Mechanisms of muscle fatigue in intense exercise. J Sports Sci 1997; 15 (3): 247-256
12. Sahlin K, Tonkonogi M, Soderlund K. Energy supply and muscle fatigue in humans. Acta Physiol Scand 1998; 162: 261-266
13. Baldwin J, Snow RJ, Gibala A, et al. Glycogen availability does not affect the TCA cycle or TAN pools during prolonged, fatiguing exercise. J Appl Physiol 2003; 94: 2181-2187
14. Sahlin K, Katz A, Broberg S. Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise. Am J Physiol 1990; 259: C834-41
15. Wagemakers AJ, Coakly JH, Edwards RH. Metabolism of branched chain amino acids and ammonia during exercise: clues from McArdle's disease. Int J Sports Med 1990; 11 Suppl. 2: 101-113
16. Cheuvront SN, Carter III R, Castellani JW, et al. Hypohydration impairs endurance exercise performance in temperate but not cold air. J Appl Physiol 2005; 99: 1972-1976
17. Gonzalez-Alonso J, Teller C, Andersen SL, et al. Influence of body temperature on the development of fatigue during prolonged exercise in the heat. J Appl Physiol 1999; 86 (3): 1032-1039
18. Cheung SS, Sleivert GG. Multiple triggers for hyperthermic fatigue and exhaustion. Exerc Sport Sci Rev 2004; 32 (3): 100-106
19. Tucker R, Rauch L, Harley YX, et al. Impaired exercise performance in the heat is associated with an anticipatory reduction in skeletal muscle recruitment. Pflugers Arch 2004; 448 (4): 422-430
20. Taylor JL, Gandevia SC. A comparison of central aspects of fatigue in submaximal and maximal contractions. J Appl Physiol 2008; 104: 542-550
21. Gandevia SC. Spinal and supraspinal factors in human muscle fatigue. Physiol Rev 2001; 81 (4): 1725-1789
22. Ishide T, Hara Y, Maher TJ, et al. Glutamate neurotransmission and nitric oxide interaction within the ven-trolateral medulla during cardiovascular responses to muscle contraction. Brain Res 2000; 874 (2): 107-115
23. Nauli SM, Pearce WM, Amer A, et al. Effect of nitric oxide and GABA interaction within ventrolateral medulla on cardiovascular responses during static muscle contraction. Brain Res 2001; 922 (2): 234-242
24. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Brain Res Rev 1993; 18 (1): 1-32
25. Meeusen R. Overtraining and the central nervous system: the missing link? Chapter 15. In: Lehman M, Foster C, Gastmann U et al., editors. Overload, performance incompetence, and regeneration in sport. New York: Kluwer academic/Plenum publishers, 1999: 187-202
26. Romanowski W, Grabiec S. The role of serotonin in the mechanism of central fatigue. Acta Physiol Pol 1974; 25 (2): 127-134
27. Heyes MP, Garnett ES, Coates G. Central dopaminergic activity influences rats ability to exercise. Life Sci 1985; 36 (7): 671-677
28. Acworth I, Nicholass J, Morgan B, et al. Effect of sustained exercise on concentrations of plasma aromatic and bran-ched-chain amino acids and brain amines. Biochem Bio-phys Res Commun 1986; 137 (1): 149-153
29. Newsholme EA, Acworth I, Blomstrand E. Amino acids, brain neurotransmitters and a function link between muscle and brain that is important in sustained exercise. In: Benzi G, editor. Advances in myochemistry. London: John Libbey Eurotext, 1987: 127-133
30. Wilson WM, Maughan RJ. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol 1992; 77 (6): 921-924
31. Struder HK, Hollmann W, Platen P, et al. Influence of paroxetine, branched-chain amino acids and tyrosine on neuroendocrine system responses and fatigue in humans. Horm Metab Res 1998; 30 (4): 188-194
32. Davis JM, Bailey SP, Jackson DA, et al. Effects of a serotonin (5-HT) agonist during prolonged exercise to fatigue in humans [abstract]. Med Sci Sports Exerc 1993; 25: S78
33. Meeusen R, Piacentini MF, Van Den Eynde S, et al. Exercise performance is not influenced by a 5-HT reuptake inhibitor. Int J Sports Med 2001; 22 (5): 329-336
34. Parise G, Bosman MJ, Boecker DR, et al. Selective serotonin reuptake inhibitors: their effect on high-intensity exercise performance. Arch Phys Med Rehabil 2001; 82 (7): 867-871
35. Roelands B, Goekint M, Buyse L, et al. Time trial performance in normal and high ambient temperature: is there a role for 5-HT? Eur J Appl Physiol 2009; 107 (1): 119-126
36. Pannier JL, Bouckaert JJ, Lefebvre RA. The antiserotonin agent pizotifen does not increase endurance performance in humans. Eur J Appl Physiol Occup Physiol 1995; 72 (1-2): 175-178
37. Marvin G, Sharma A, Aston W, et al. The effects of buspirone on perceived exertion and time to fatigue in man. Exp Physiol 1997; 82 (6): 1057-1060
38. Meeusen R, Roeykens J, Magnus L, et al. Endurance performance in humans: the effect of a dopamine precursor or a specific serotonin (5-HT2A/2C) antagonist. Int J Sports Med 1997; 18 (8): 571-577
39. Piacentini MF, Meeusen R, Buyse L, et al. No effect of a selective serotonergic/noradrenergic reuptake inhibitor on endurance performance. Eur J Sport Sci 2002; 2 (6): 1-10
40. Piacentini MF, Meeusen R, Buyse L, et al. No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists. Med Sci Sports Exerc 2002; 34 (7): 1189-1193
41. Roelands B, Goekint M, Heyman E, et al. Acute norepinephrine reuptake inhibition decreases in normal and high ambient temperature. J Appl Physiol 2008; 105 (1): 206-212
42. Piacentini MF, Meeusen R, Buyse L, et al. Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor. Br J Sports Med 2004; 38 (2): 129-133
43. Watson P, Hasegawa H, Roelands B, et al. Acute dopamine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions. J Physiol 2005; 565 (Pt 3): 873-883
44. Swart J, Lamberts RP, Lambert MI, et al. Exercising with reserve: evidence that the CNS regulates prolonged exercise performance. Br J Sports Med 2009; 43 (10): 782-788
45. Roelands B, Hasegawa H, Watson P, et al. Acute DA reuptake inhibition enhances performance in warm but not temperate conditions. Med Sci Sports Exerc 2008; 40 (5): 879-958
46. Jacobs I, Bell DG. Effects of acute modafinil ingestion on exercise time to exhaustion. Med Sci Sports Exerc 2004; 36 (6): 1078-1082
47. Strachan A, Leiper J, Maughan R. The failure of acute paroxetine administration to influence human exercise capacity, RPE or hormone responses during prolonged exercise in a warm environment. Exp Physiol 2004; 89 (6): 657-664
48. Strachan AT, Leiper JB, Maughan RJ. Serotonin 2C receptor blockade and thermoregulation during exercise in the heat. Med Sci Sports Exerc 2005; 37 (3): 389-394
49. Bridge MW, Weller AS, Rayson M, et al. Responses to exercise in the heat related to measures of hypothalamic serotonergic and dopaminergic function. Eur J Appl Physiol 2003; 89 (5): 451-459
50. Roelands B, Hasegawa H, Watson P, et al. Performance and thermoregulatory effects of chronic bupropion administration in the heat. Eur J Appl Physiol 2009; 105 (3): 493-498
51. Jacobs BL, Eubanks EE. A comparison of the locomotor effects of 5-hydroxytryptamine and 5-hydroxytryptophan administered via two systemic routes. Pharmacol Bio-chem Behav 1974; 2 (1): 137-139
52. Hillegaart V, Wadenberg ML, Ahlenius S. Effects of 8-OHDPAT on motor activity in the rat. Pharmacol Biochem Behav 1989; 32 (3): 797-800
53. Wilckens T, Schweiger U, Pirke KM. Activation of alpha 2adrenoceptors suppresses excessive wheel running in the semistarvation-induced hyperactive rat. Pharmacol Bio-chem Behav 1992; 43 (3): 733-738
54. Bailey SP, Davis JM, Ahlborn EN. Effect of increased brain serotonergic activity on endurance performance in the rat. Acta Physiol Scand 1992; 145 (1): 75-76
55. Bailey SP, Davis JM, Ahlborn EN. Serotonergic agonists and antagonists affect endurance performance in the rat. Int J Sports Med 1993; 14 (6): 330-333
56. Bailey SP, Davis JM, Ahlborn EN. Neuroendocrine and substrate responses to altered brain 5-HT activity during prolonged exercise to fatigue. J Appl Physiol 1993; 74 (6): 3006-3012
57. Gerald MC. Effects of (+)-amphetamine on the treadmill endurance performance of rats. Neuropharmacology 1978; 17 (9): 703-704
58. Chaouloff F, Laude D, Merino D, et al. Amphetamine and alpha-methyl-p-tyrosine affect the exercise-induced imbalance between the availability of tryptophan and synthesis of serotonin in the brain of the rat. Neuro-pharmacology 1987; 26 (8): 1099-1106
59. Kalinski MI, Dluzen DE, Stadulis R. Methamphetamine produces subsequent reductions in running time to exhaustion in mice. Brain Res 2001; 921 (1-2): 160-164
60. Connor TJ, Kelliher P, Harkin A, et al. Reboxetine attenuates forced swim test-induced behavioural and neuro-chemical alterations in the rat. Eur J Pharmacol 1999; 379 (2-3): 125-133
61. Lima NR, Coimbra CC, Marubayashi U. Effect of intracerebroventricular injection of atropine on metabolic responses during exercise in untrained rats. Physiol Behav 1998; 64 (1): 69-74
62. Rodrigues AG, Lima NR, Coimbra CC, et al. Intracerebroventricular physostigmine facilitates heat loss mechanisms in running rats. J Appl Physiol 2004; 97 (1): 333-338
63. Hasegawa H, Ishiwata T, Saito T, et al. Inhibition of the preoptic area and anterior hypothalamus by tetrodotoxin alters thermoregulatory functions in exercising rats. J Appl Physiol 2005; 98 (4): 1458-1462
64. Hasegawa H, Piacentini MF, Sarre S, et al. Influence of brain catecholamines on the development of fatigue in exercising rats in the heat. J Physiol 2008; 586 (1): 141-149
65. Frazer A, Hensler J. Serotonin: molecular and medical aspects. In: Siegel GJ, Agranoff BW, Albers RW, et al., editors. Basic neurochemistry. 5th ed. New York: Raven Press, 1994: 283-308
66. Meeusen R, De Meirleir K. Exercise and brain neurotransmission. Sports Med 1995; 20 (3): 160-188
67. Weiner N, Molinoff PB. Catecholamines. In: Siegel GJ, Agranoff BW, Albers RW, et al., editors. Basic neuro-chemistry. New York: Raven Press, 1994: 261-281
68. Nestler EJ, Hyman SE, Malenka RC. Molecular neuropharmacology: a foundation for clinical neuroscience. New York: McGraw-Hill, 2001
69. Struder HK, Weicker H. Physiology and pathophysiology of the serotonergic system and its implications on mental and physical performance (part II). Int J Sports Med 2001; 22 (7): 482-497 (Pubitemid 32980383)
70. Zifa E, Fillion G. 5-Hydroxytriptamine receptors. Pharmacol Rev 1992; 44 (3): 402-440
71. Hasegawa H, Meeusen R, Sarre S, et al. Acute dopamine/ noradrenaline reuptake inhibition increases brain and core temperature in rats. J Appl Physiol 2005; 99 (4): 1397-1401
72. Piacentini MF, Clinckers R, Meeusen R, et al. Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. J Appl Physiol 2003; 95 (2): 652-656
73. Borg G, Edstrom CG, Linderholm H, et al. Changes in physical performance induced by amphetamine and amobarbital. Psychopharmacologia 1972; 26 (1): 10-18
74. Meeusen R, Watson P, Dvorak J. The brain and fatigue: new opportunities for nutritional interventions? J Sports Sci 2006; 24: 773-782
75. Quan N, Xin L, Blatteis C. Microdialysis of norepinephrine into preoptic area of guinea pigs: characteristics of hypo-thermic effect. Am J Physiol 1991; 261: R378-85
76. Gisolfi C, Christman J. Thermal effects of injecting norepinephrine into hypothalamus of the rat during rest and exercise. J Appl Physiol 1980; 49: 937-941
77. Myers R, Beleslin D, Rezvani A. Hypothermia: role of alpha 1and alpha 2-noradrenergic receptors in the hypothalamus of the cat. Pharmacol Biochem Behav 1987; 26: 373-379
78. Quan N, Xin L, Ungar A, et al. Preoptic norepinephrineinduced hypothermia is mediated by alpha 2-adrenocep-tors. Am J Physiol 1992; 262: R407-11
79. Nagashima K. Central mechanisms for thermoregulation in a hot environment. Industrial Health 2006; 44: 359-367
80. Parkin JM, Carey MF, Zhao S, et al. Effect of ambient temperature on human skeletal muscle metabolism during fatiguing submaximal exercise. J Appl Physiol 1999; 86 (3): 902-908
81. Galloway SD, Maughan RJ. Effects of ambient temperature on the capacity to perform prolonged cycle exercise in man. Med Sci Sports Exerc 1997; 29 (9): 1240-1249
82. Nielsen B, Savard G, Richter EA, et al. Muscle blood flow and metabolism during exercise and heat stress. J Appl Physiol 1990; 69: 1040-1046
83. Nielsen B, Hales JR, Strange S, et al. Human circulatory and thermoregulatory adaptations with heat acclimation and exercise in a hot, dry environment. J Physiol 1993; 460: 467-485
84. Nielsen B, Strange S, Christensen NJ, et al. Acute and adaptive responses in human to exercise in a warm, humid environment. Pflugers Arch 1997; 434: 49-56
85. Gonzalez-Alonso J, Calbet JA, Nielsen B. Metabolic and thermodynamic responses to hydration-induced reductions in muscle blood flow in exercising humans. J Physiol 1999; 520: 577-589
86. Bruck K, Olschewski H. Body temperature related factors diminishing the drive to exercise. Can J Sports Sci 1987; 65: 1274-1280
87. Cheung SS. Hyperthermia and voluntary exhaustion: integrating models and future challenges. Appl Physiol Nutr Metab 2007; 32: 808-817
88. MacDougall JD, Reddan WG, Layton CR, et al. Effects of metabolic hyperthermia on performance during heavy prolonged exercise. J Appl Physiol 1974; 36: 538-544
89. Walters TJ, Ryan KL, Tate LM, et al. Exercise in the heat is limited by a critical internal temperature. J Appl Physiol 2000; 89 (2): 799-806
90. Nybo L. Hyperthermia and fatigue. J Appl Physiol 2008; 104: 871-878
91. Marino FE, Lambert MI, Noakes TD. Superior performance of African runners in warm humid but not in cool environmental conditions. J Appl Physiol 2004; 96 (1): 124-130
92. Feleder C, Perlik V, Blatteis C. Preoptic alpha 1and alpha 2-noradrenergic agonists induce, respectively, PGE2-in-dependent and PGE2-dependent hyperthermic responses in guinea pigs. Am J Physiol Regul Integr Comp Physiol 2004; 286: R1156-66
93. Imbery T, Irdmusa M, Speidell A, et al. The effects of cirazoline, an alpha-1 adrenoreceptor agonist, on the firing rates of thermally classified anterior hypothalamic neurons in rat brain slices. Brain Res 2008; 1193: 93-101
94. Watanabe T, Morimoto A, Murakami N. Effect of amines on temperature-responsive neurons in slice preparation of rat brain stem. Am J Physiol 1986; 250: R553-9
95. Feldberg W, Myers RD. A new concept of temperature regulation by amines in the hypothalamus [letter]. Nature 1963; 200: 1325
96. Cox B, Kerwin R, Lee T, et al. A dopaminergic-5-hydroxytriptamine link in the hypothalamic pathways which mediates heat loss in the rat. J Physiol Paris 1980; 303: 9-21
97. Clark WG, Lipton JM. Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants (II). Neurosci Biobehav Rev 1986; 10: 153-220
98. Ishiwata T, Saito T, Hasegawa H, et al. Changes of body temperature and extracellular serotonin level in the pre-optic area and anterior hypothalamus after thermal or serotonergic pharmacological stimulation of freely moving rats. Life Sci 2004; 75 (22): 2665-2675
99. Hasegawa H, Yazawa T, Yasumatsu M, et al. Alteration in dopamine metabolism in the thermoregulatory center of exercising rats. Neurosci Lett 2000; 289 (3): 161-164
100. Ishiwata T, Saito T, Hasegawa H, et al. Changes of body temperature and thermoregulatory responses of freely moving rats during GABAergic pharmacological stimulation to the preoptic area and anterior hypothalamus in several ambient temperatures. Brain Res 2005; 1048 (1-2): 32-40
101. Ishiwata T, Hasegawa H, Yasumatsu M, et al. The role of preoptic area and anterior hypothalamus and median ra-phe nucleus on thermoregulatory system in freely moving rats. Neurosci Lett 2001; 306 (1-2): 126-128
102. Ishiwata T, Hasegawa H, Yazawa T, et al. Functional role of preoptic area and anterior hypothalamus in thermo-regulation in freely moving rats. Neurosci Lett 2002; 325 (3): 167-170
103. Yehuda S, Wurtmann RJ. Release of brain dopamine as the probable mechanism for the hypothermic effect by D-amphetamine. Nature 1972; 240 (5382): 477-478
104. Bowyer JF, Tank AW, Newport GD, et al. The influence of environmental temperature on the transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J Pharmacol Exp Ther 1992; 260 (2): 817-824
105. Malberg JE, Seiden LS. Small changes in ambient temperature cause large changes in 3,4-methylenedioxy-methamphetamine (MDMA)-induced serotonin neuro-toxicity and core body temperature in the rat. J Neurosci 1998; 18 (13): 5086-5094
106. Myles BJ, Jarrett LA, Broom LJ, et al. The effects of methamphetamine on core body temperature in the rat Part 1: chronic treatment and ambient temperature. Psycho-pharmacol 2008; 198: 301-311
107. Jeukendrup A. Carbohydrate intake during exercise and performance. Nutrition 2004; 20 (7-8): 669-677
108. Hargreaves M, Febbraio M. Limits to exercise performance in the heat. Int J Sports Med 1998; 19 (S2): S115-6
109. Lin M, Tsay H, Su W, et al. Changes in extracellular serotonin in rat hypothalamus affect thermoregulatory function. Am J Physiol 1998; 274 (5 Pt 2): R1260-7
110. Sugimoto Y, Ohkura M, Inoue K, et al. Involvement of the 5-HT (2) receptor in hyperthermia induced by p-chlor-oamphetamine, a serotonin releasing drug in mice. Eur J Pharmacol 2000; 403 (3): 225-228
111. Committee for Proprietary Medicinal Products. Bupropion hydrochloride, international non-proprietary name (INN): bupropion. European Agency for the Evaluation of Medicinal Products; CPMP/27610/02 2002 Nov 28 [online]. Available from URL: http://www.ema.europa. eu/pdfs/human/referral/bupropion/2761002en.pdf [Accessed 2010 Feb 18]
112. Nomikos GG, Damsma G, Wenkstern BA, et al. Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis. Neuropsychopharmacology 1989; 2: 273-279
113. Jefferson JW, Pradko JF, Muir KT. Bupropion for major depressive disorder: pharmacokinetic and formulation considerations. Clin Ther 2005; 27 (11): 1685-1695
114. Learned-Coughlin SM, Bergstrom M, Savitcheva I, et al. In vivo activity of bupropion at the human dopamine transporter as measured by Positron Emission Tomography. Biol Psychiatry 2003; 54: 800-805
115. Sulzer D, Sonders MS, Poulsen NW, et al. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005; 75 (6): 406-433
116. Kovacs EM, Stegen JH, Brouns F. Effect of caffeinated drinks on substrate metabolism, caffeine excretion, and performance. J Appl Physiol 1998; 85: 709-715
117. Tarnapolsky M, Cupido C. Caffeine potentiates low frequency skeletal muscle force in habitual and nonhabitual caffeine consumers. J Appl Physiol 2000; 89: 1719-1724
118. Cox GR, Desbrow B, Montgomery PG, et al. Effect of different protocols of caffeine intake on metabolism and endurance performance. J Appl Physiol 2002; 93: 990-999
119. Conway KJ, Orr R, Stannard SR. Effect of a divided caffeine dose on endurance cycling performance, postexercise urinary caffeine concentration, and plasma paraxanthine. J Appl Physiol 2003; 94: 1557-1562
120. Glaister M, Howatson G, Abraham CS, et al. Caffeine supplementation and multiple sprint running performance. Med Sci Sports Exerc 2008; 40 (10): 1835-1840
121. Hoogervorst E,BandelowS, SchmittJ,etal. Caffeine improves physical and cognitive performance during exhaustive exercise. Med Sci Sports Exerc 2008; 40 (10): 1841-1851
122. Cheuvront SN, Ely BR, Kenefick RW, et al. No effect of nutritional adenosine receptor agonists on exercise performance in the heat. Am J Physiol Regul Integr Comp Physiol 2009 Feb; 296 (2): R394-401